168 related articles for article (PubMed ID: 19370596)
1. Sacral neuromodulation with implanted devices for urinary storage and voiding dysfunction in adults.
Herbison GP; Arnold EP
Cochrane Database Syst Rev; 2009 Apr; (2):CD004202. PubMed ID: 19370596
[TBL] [Abstract][Full Text] [Related]
2. Pathways and parameters of sacral neuromodulation in rats.
Hokanson JA; Langdale CL; Grill WM
Am J Physiol Renal Physiol; 2023 Dec; 325(6):F757-F769. PubMed ID: 37795537
[TBL] [Abstract][Full Text] [Related]
3. [Functional-neurosurgical treatment options for functional pelvic floor disorders : Value of sacral neuromodulation].
Maciaczyk J; Bara G; Kurth F
Radiologie (Heidelb); 2023 Nov; 63(11):835-843. PubMed ID: 37823893
[TBL] [Abstract][Full Text] [Related]
4. Sacral nerve stimulation: neuromodulation for voiding dysfunction and pain.
Mayer RD; Howard FM
Neurotherapeutics; 2008 Jan; 5(1):107-13. PubMed ID: 18164489
[TBL] [Abstract][Full Text] [Related]
5. Treatment of the infected sacral nerve stimulator: A scoping review.
Wynn J; Kelsey E; McLeod K
Neurourol Urodyn; 2024 Mar; 43(3):579-594. PubMed ID: 38318878
[TBL] [Abstract][Full Text] [Related]
6. Real-time prediction of bladder urine leakage using fuzzy inference system and dual Kalman filtering in cats.
Qasemi A; Aminian A; Erfanian A
Sci Rep; 2024 Feb; 14(1):3879. PubMed ID: 38365925
[TBL] [Abstract][Full Text] [Related]
7. Splenic Nerve Neuromodulation Reduces Inflammation and Promotes Resolution in Chronically Implanted Pigs.
Sokal DM; McSloy A; Donegà M; Kirk J; Colas RA; Dolezalova N; Gomez EA; Gupta I; Fjordbakk CT; Ouchouche S; Matteucci PB; Schlegel K; Bashirullah R; Werling D; Harman K; Rowles A; Yazicioglu RF; Dalli J; Chew DJ; Perkins JD
Front Immunol; 2021; 12():649786. PubMed ID: 33859641
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin injections for adults with overactive bladder syndrome.
Duthie JB; Vincent M; Herbison GP; Wilson DI; Wilson D
Cochrane Database Syst Rev; 2011 Dec; (12):CD005493. PubMed ID: 22161392
[TBL] [Abstract][Full Text] [Related]
9. Electrical stimulation of the posterior tibialis nerve improves symptoms of poststroke neurogenic overactive bladder in men: a randomized controlled trial.
Monteiro ÉS; de Carvalho LB; Fukujima MM; Lora MI; do Prado GF
Urology; 2014 Sep; 84(3):509-14. PubMed ID: 25168524
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and treatment of headache in the ambulatory care setting: a review of classic presentations and new considerations in diagnosis and management.
Hale N; Paauw DS
Med Clin North Am; 2014 May; 98(3):505-27. PubMed ID: 24758958
[TBL] [Abstract][Full Text] [Related]
11. Sustained effectiveness of 10 kHz high-frequency spinal cord stimulation for patients with chronic, low back pain: 24-month results of a prospective multicenter study.
Al-Kaisy A; Van Buyten JP; Smet I; Palmisani S; Pang D; Smith T
Pain Med; 2014 Mar; 15(3):347-54. PubMed ID: 24308759
[TBL] [Abstract][Full Text] [Related]
12. Patient-perceived differences between constant current and constant voltage spinal cord stimulation systems.
Washburn S; Catlin R; Bethel K; Canlas B
Neuromodulation; 2014 Jan; 17(1):28-35; discussion 35-6. PubMed ID: 23837549
[TBL] [Abstract][Full Text] [Related]
13. Occipital nerve stimulation for intractable chronic cluster headache or migraine: a critical analysis of direct treatment costs and complications.
Mueller O; Diener HC; Dammann P; Rabe K; Hagel V; Sure U; Gaul C
Cephalalgia; 2013 Dec; 33(16):1283-91. PubMed ID: 23814173
[TBL] [Abstract][Full Text] [Related]
14. Prospective and randomized comparison of electrical stimulation of the posterior tibial nerve versus oxybutynin versus their combination for treatment of women with overactive bladder syndrome.
Souto SC; Reis LO; Palma T; Palma P; Denardi F
World J Urol; 2014 Feb; 32(1):179-84. PubMed ID: 23749315
[TBL] [Abstract][Full Text] [Related]
15. A multicenter, prospective trial to assess the safety and performance of the spinal modulation dorsal root ganglion neurostimulator system in the treatment of chronic pain.
Liem L; Russo M; Huygen FJ; Van Buyten JP; Smet I; Verrills P; Cousins M; Brooker C; Levy R; Deer T; Kramer J
Neuromodulation; 2013; 16(5):471-82; discussion 482. PubMed ID: 23668228
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of percutaneous and paddle lead implantation for spinal cord stimulation: a comparative analysis of complications, reoperation rates, and health-care costs.
Babu R; Hazzard MA; Huang KT; Ugiliweneza B; Patil CG; Boakye M; Lad SP
Neuromodulation; 2013; 16(5):418-26; discussion 426-7. PubMed ID: 23647789
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of melatonin in the treatment of endometriosis: a phase II, randomized, double-blind, placebo-controlled trial.
Schwertner A; Conceição Dos Santos CC; Costa GD; Deitos A; de Souza A; de Souza IC; Torres IL; da Cunha Filho JS; Caumo W
Pain; 2013 Jun; 154(6):874-81. PubMed ID: 23602498
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous nerve stimulation in chronic neuropathic pain patients due to spinal cord injury: a pilot study.
Kopsky DJ; Ettema FW; van der Leeden M; Dekker J; Stolwijk-Swüste JM
Pain Pract; 2014 Mar; 14(3):252-9. PubMed ID: 23586844
[TBL] [Abstract][Full Text] [Related]
19. Peripheral nerve field stimulation for the management of localized chronic intractable back pain: results from a randomized controlled study.
McRoberts WP; Wolkowitz R; Meyer DJ; Lipov E; Joshi J; Davis B; Cairns KD; Barolat G
Neuromodulation; 2013; 16(6):565-74; discussion 574-5. PubMed ID: 23577773
[TBL] [Abstract][Full Text] [Related]
20. Novel spinal cord stimulation parameters in patients with predominant back pain.
Tiede J; Brown L; Gekht G; Vallejo R; Yearwood T; Morgan D
Neuromodulation; 2013; 16(4):370-5. PubMed ID: 23433237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
